← Eichor
Study identifier: NCT07301242 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Population Pharmacokinetics and Pharmacodynamics of Ciprofol

Condition: Hip Fractures (ICD-10 72.01-72.2) · Osteoarthritis, Knee and Hip · Femoral Neck Fractures  ·  Sponsor: Shanghai Geriatric Medical Center

PhaseN/A
Planned participants50
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to learn how the anesthetic drug ciprofol works in older adults who are having limb surgery under general anesthesia at Shanghai Geriatric Medical Center. The study will help researchers build a population model to better understand how the drug moves through the body (PK) and how it affects patients (PD). This model may help doctors use a Target-Controlled Infusion (TCI) system to adjust the drug dose more precisely. The main question it aims to answer is: Does ciprofol work safely and effectively in older adults during orthopedic surgery? Participants already receiving ciprofol as part of their regular anesthesia care will: 1. Provide blood samples at different time points during and after surgery. 2. Have their vital signs and anesthesia-related data recorded before, during, and after surgery. 3. Be monitored for side effects and recovery indicators such as the Aldrete score and signs of postoperative delirium. Researchers will use this information to: 1. Build and test a population PK/PD model for ciprofol. 2. Simulate recommended TCI dosing plans. 3. Explore how individual responses to ciprofol relate to recovery and safety outcomes. This study may help improve anesthesia care for elder adults by making drug dosing safer and more effective.

This description comes directly from the study's public registry record.

Talk to the study team

Xue Zhang  ·  02164175590  ·  zx02190554@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Geriatric Medical CenterShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07301242